We are live on
!
Find out more
M
Mirova Portfolio holdings
AUM
$2.46B
1-Year Est. Return
11.42%
This Fund
S&P 500
This Quarter
Est. Return
+10.13%
1 Year Est. Return
+11.42%
3 Year Est. Return
+32%
5 Year Est. Return
+23.08%
10 Year Est. Return
–
AUM
$709M
AUM Growth
+$153M
(+28%)
Cap. Flow
+$113M
Cap. Flow
% of AUM
15.93%
Top 10 Holdings %
Top 10 Hldgs %
44.37%
Holding
141
New
7
Increased
61
Reduced
36
Closed
22
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Xylem
XYL
|
+$7.03M |
| 2 |
Trimble
TRMB
|
+$6.54M |
| 3 |
Cadence Design Systems
CDNS
|
+$5.73M |
| 4 |
Sprouts Farmers Market
SFM
|
+$5.64M |
| 5 |
Colgate-Palmolive
CL
|
+$5.36M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$5.51M |
| 2 |
Exponent
EXPO
|
+$2.07M |
| 3 |
Cisco
CSCO
|
+$2.03M |
| 4 |
Sunrun
RUN
|
+$1.84M |
| 5 |
Bright Horizons
BFAM
|
+$1.52M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.01% |
| 2 | Healthcare | 17.43% |
| 3 | Industrials | 16.91% |
| 4 | Materials | 8.62% |
| 5 | Consumer Discretionary | 6.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Darling Ingredients
DAR
$9.28B
| – | – |
-1,808
| Closed | -$56.5K |
|
127
Dover
DOV
$27.5B
| – | – |
-460
| Closed | -$80.8K |
|
128
Greif
GEF
$4.7B
| – | – |
-8,228
| Closed | -$452K |
|
129
Hain Celestial
HAIN
$46.2M
| – | – |
-9,366
| Closed | -$38.9K |
|
130
Kadant
KAI
$3.77B
| – | – |
-1,864
| Closed | -$628K |
|
131
Merck
MRK
$326B
| – | – |
-3,255
| Closed | -$292K |
|
132
Norfolk Southern
NSC
$77.1B
| – | – |
-701
| Closed | -$166K |
|
133
Nucor
NUE
$59.9B
| – | – |
-733
| Closed | -$88.2K |
|
134
Omnicom Group
OMC
$24.6B
| – | – |
-7,954
| Closed | -$659K |
|
135
Otis Worldwide
OTIS
$28B
| – | – |
-4,324
| Closed | -$446K |
|
136
ResMed
RMD
$30.1B
| – | – |
-416
| Closed | -$93.1K |
|
137
Sensata Technologies
ST
$6.73B
| – | – |
-13,326
| Closed | -$323K |
|
138
Steel Dynamics
STLD
$37.3B
| – | – |
-1,024
| Closed | -$128K |
|
139
Waters Corp
WAT
$37.9B
| – | – |
-177
| Closed | -$65.2K |
|
140
West Pharmaceutical
WST
$23.9B
| – | – |
-155
| Closed | -$34.7K |
|
|
SW
141
Smurfit Westrock
SW
$27B
| – | – |
-3,143
| Closed | -$142K |
|
Similar funds
BW
SCM
GWM
TW
JC
SG
RL
QT
Mirova's Q2 2025 Portfolio in Review
As of Q2 2025, Mirova held 141 positions worth $709M, up 28% from $556M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Mirova deployed $113M of net new capital in Q2 2025, opening 7 new positions and adding to 61 existing holdings. Its largest new stake was Hubbell: 5,000 shares worth $2.04M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 31% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Thermo Fisher Scientific, an estimated $5.51M trimmed.
- Mirova's largest Q2 2025 buy was Hubbell: 5,000 shares worth $2.04M.
- Mirova added most to Xylem in Q2 2025, an estimated $7.03M increase.
- Mirova's biggest Q2 2025 reduction was Thermo Fisher Scientific, cutting an estimated $5.51M.
- Mirova fully exited Omnicom Group in Q2 2025, selling an estimated $659K.
- Mirova's ten largest holdings make up 44% of its $709M portfolio in Q2 2025.
- Mirova opened 7 new positions and closed 22 in Q2 2025.
- Mirova's portfolio value rose 28% quarter-over-quarter to $709M.
Based on Mirova's 13F filing for Q2 2025, filed 13 Aug 2025.